Vascular endothelial growth factor pathway

Pharmacogenet Genomics. 2010 May;20(5):346-9. doi: 10.1097/FPC.0b013e3283364ed7.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Angiogenesis Inhibitors / pharmacology*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / pharmacology
  • Bevacizumab
  • Clinical Trials as Topic
  • Gene Expression Regulation, Neoplastic
  • Genotype
  • Humans
  • Models, Biological
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism*
  • Pharmacogenetics
  • Vascular Endothelial Growth Factor A / metabolism*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Vascular Endothelial Growth Factor A
  • Bevacizumab